Results 11 to 20 of about 858,870 (284)

Educating Medical Students on How to Prescribe Anti-Hyperglycaemic Drugs: A Practical Guide

Diabetology, 2023
In the light of the rapidly increasing global incidence of, and therapeutic arsenal for, diabetes type 2, this brief report underscores the need for advancements in clinical pharmacology and therapeutics (CPT) education with regard to diabetes type 2. We
Erik M. Donker, Andrej Belančić, Joost D. Piët, Dinko Vitezić, Jelle Tichelaar, on behalf of the Clinical Pharmacology and Therapeutics Teach the Teacher (CP4T) Program and the Early Career Pharmacologists of the European Association for Clinical Pharmacology and Therapeutics (EACPT)   +5 more
doaj   +1 more source

Basic & Clinical Pharmacology

Central Asian Journal of Medical Sciences, 2022
No abstract in ...
Narantungalag Dorjsuren
doaj   +1 more source

Basic & Clinical Pharmacology 14th Edition

Central Asian Journal of Medical Sciences, 2020
No abstract  in ...
Narantungalag Dorjsuren
doaj   +1 more source

Clinical pharmacology of cefazolin

Advances in Biomedical and Health Sciences, 2022
Cefazolin is a first-generation cephalosporin that is active against gram-positive bacteria and has modest activity against gram-negative organisms, and cefazolin is excreted by glomerular filtration.
Gian Maria Pacifici
doaj   +1 more source

TEACHING CLINICAL PHARMACOLOGY OF UNDERGRADUATE MEDICAL STUDENTS IN EUROPE: CURRENT TRENDS AND PROSPECTS. Review

Медична наука України, 2022
Relevance. Among the professional competencies, a graduate of a medical faculty should not only determine drugs for the treatment of typical diseases, but also be able to correct errors in prescribing; warn, identify and report adverse drug reactions ...
M.V. Khaitovych, L.L. Pinskyy, О.А. Temirova, V.S. Potaskalova, N.O. Saveliieva-Kulyk, V.O. Polovinka   +5 more
doaj   +1 more source

Neonatal pharmacology and clinical implications

Drugs in Context, 2019
During the neonatal period, there is physiological immaturity of organs, systems and metabolic pathways that influences the pharmacokinetics and pharmacodynamics of administered drugs, the dosage of which should be constantly amended, considering the ...
Antonio Ruggiero, Anna Ariano, Silvia Triarico , Michele Antonio Capozza, Pietro Ferrara, Giorgio Attinà   +5 more
doaj   +1 more source

Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain [PDF]

, 2012
The development of clinica lpractice recommendations or guidelines for the clinical use of biomarkers is an issue of great importance withr regard to adverse drug reactions.The poten-tial of pharmacogenomicbiomarkers has been extensively investigated in
Abad Santos, Francisco, Aldea, Ana, Alonso-Navarro, Hortensia, Bernal, María Luisa, Borobia, Alberto M., Borràs, Emma, Carballo, Miguel, Carvajal, Alfonso, García-Agúndez, José Augusto, García-Martín, Elena, García-Muñiz, José D., Gervasini, Guillermo, Jiménez-Jiménez, Félix Javier, Lucena, María Isabel, Martínez, Carmen, Sacristán, José A., Salado, Inés, Sinués, Blanca, Vicente, Jorge   +18 more
core   +4 more sources

A phase I, single and continuous dose administration study on the safety, tolerability, and pharmacokinetics of neorudin, a novel recombinant anticoagulant protein, in healthy subjects

Pharmacology Research & Perspectives, 2021
The aim of this study was to evaluate the tolerability, safety, and pharmacokinetics of single and continuous dose administration of recombinant neorudin (EPR‐hirudin, EH) by intravenous administration in healthy subjects, and to provide a safe dosage ...
Yubin Liu, Meixia Wang, Xiaona Dong, Jia He, Lin Zhang, Ying Zhou, Xia Xia, Guifang Dou, Chu‐tse Wu, Jide Jin   +9 more
doaj   +1 more source

Neonatal clinical pharmacology [PDF]

Pediatric Anesthesia, 2013
SummaryEffective and safe drug administration in neonates should be based on integrated knowledge on the evolving physiological characteristics of the infant who will receive the drug and the pharmacokinetics (PK) and pharmacodynamics (PD) of a given drug.
Karel Allegaert, John N. van den Anker, John N. van den Anker, John N. van den Anker, Marc Van de Velde   +4 more
openaire   +3 more sources

Targeting inflammation to reduce cardiovascular disease risk [PDF]

, 2017
This joint themed section of the British Journal of Pharmacology and the British Journal of Clinical Pharmacology stems from a joint British Pharmacological Society – Italian Society of Pharmacology symposium held at the 37th National Congress of the ...
Cirino, Guiseppe, Maffia, Pasquale
core   +1 more source